In addition to retrospectively analyzing the associations with OS and RFS in breast cancer patients, we further determined the prognostic value of intra-tumoral CD4+ and CD8+ T cells for the prediction of risk of breast cancer development during the follow-up period. This evidence concerns the gene CD4 and breast cancer.